BioArctic AB (publ) (STO:BIOA.B)
Sweden · Delayed Price · Currency is SEK 336.80
-1.59 (-0.47%)
At close: May 28, 2026
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 30.2 billion as of May 28, 2026. Its market cap has increased by 89.73% in one year.
Market Cap
30.20B
Enterprise Value
28.21B
Revenue
1.15B
Ranking
n/a
PE Ratio
141.89
Stock Price
336.80
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 30.20B, an increase of 1,082.58%. That is a compound annual growth rate of 33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 30.20B | 9.62% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 31.31B |
| Hansa Biopharma AB | 3.42B |
| Vicore Pharma Holding AB | 3.33B |
| Egetis Therapeutics AB | 2.82B |
| Flerie AB | 2.24B |
| BioInvent International AB | 1.91B |
| Saniona AB | 1.89B |
| Genovis AB (publ.) | 1.27B |